To cite this paper use one of the standards below:
INTRODUCTION: Giardiasis is one of the main diarrheal diseases known worldwide that is caused by the microaerophilic flagellate protozoan Giardia intestinalis. The pathogenesis of the disease originates from the strong adhesion of trophozoites to the intestinal epithelium along with the release of proteolytic enzymes, extracellular vesicles (EVs) and other virulence mechanisms not yet fully understood, causing tissue disruption and production of diarrhea and damage to the body. However, there is clonal diversity in Giardia intestinalis (GI) related to genotypes A and B responsible for human infection and this frequency of recombination influences several factors like metabolism, biochemistry and sensitivity to the drug. In the present proposal we intend to characterize clones of Giardia intestinalis from one multiclonal Giardia intestinalis Albendazole resistant isolated and clones from wild type Giardia intestinalis strain (WB). We are doing a phenotypic characterization in order to obtain more information to understand mechanisms of pathogenicity and patterns of transmission of the disease. METHODS: Clinical isolates of Giardia intestinalis (Botucatu, São Paulo and WB strain (genotype A) was maintained in TYI-S-33 medium (10% adult bovine serum and 1% streptomycin antibiotic/ penicillin) and the clones were obtain through clonal dilution in glass tubes, where the probability was less than 1 parasite per tube. The growth curve of clones WB, LR05, LR23 and LR44 was evaluated daily for 96h. For EVs isolation, all the clones were stimulated with different concentrations of calcium and isolated by differential centrifugation (15.000 xg/1h for LEVs). The analysis of size and concentration of EVs was made by Nanoparticle tracking analysis. The drug assay was performed on all clones with albendazole (ABZ) in 3 different concentrations and analyzed daily for 72h. RESULTS: all clinical clones had growth rate higher than WB clone. Clones LR23 and LR44 from isolated had IC50 higher than Wild Type WB clones. Differences in the secretion of EVs was observed in LR05 being a major producer compared with the rest of clinical clones and WB. Assays to analyze the ability of GI to adhere host cells and proteomic from albendazole-Resistant Giardia Intestinalis EVs and WB EVs will be made to complete the phenotypic analysis. The composition of EVs and the fitness of GI resistant to albendazole clones could improve the understanding of the physiopathology of the disease, the participation of Evs at the generation of resistance to albendazole and the impact of clonal diversity in Giardia intestinalis. FINANCIAL SUPPORT: CNPq and CAPES.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper